Buy Imbruvica from Discount Pharmacy
We are a leading Canadian mail-order pharmacy service focusing on both on prescription cost-containment and patient safety. We only work with a small network of trusted and reputable international pharmacies and fulfillment centers, giving you access to authentic medications at low prices every day. All medications are shipped directly to you from our affiliated licensed international and Canadian pharmacies and fulfillment centers. Our staff are knowledgeable and efficient to ensure that your shopping experience is hassle free. Save on prescription drugs like Imbruvica as well as other prescription drugs like Abilify, Celexa, Diovan, Gleevec, Nuvigil, Norvasc, Provigil, Lunesta, Viagra, Zyprexa.
10 Great Reasons to Choose Our Service!
Live and professional customer service ready to help you order Imbruvica.
Safe and secure service that values your business and will safeguard your privacy.
All prescription orders come with a unique tracking number from our fulfillment partner.
Live and friendly customer service staff available 5 days a week ready to help your questions or assist you in ordering.
The Canadian dollar performs weaker than the US dollar. This gives American more spending power when buying from Canada.
All of your drug prescriptions are reviewed by a Canadian physician and filled by a Canadian licensed pharmacists from our Canadian Pharmacy.
Fast shipping means you will receive your prescription drugs from the pharmacy in only 2-3 weeks from the time you place your order.
Regulated prices by the Canadian government allows Americans to buy at cheaper prices compared to US pharmacies.
You can save even more when you order generic drugs. Canadian generic prescriptions drugs are the exact same quality and potency as brand name prescriptions drugs, but cost less.
Many towns, cities and states are encouraging their citizens to consider buying Imbruvica and other prescription medications outside USA.
Why Are Cancer Drugs So Expensive?
The high cost of cancer drugs is related to a number of factors. It is very very expensive to move findings from bench to bedside and to perform all the regulatory studies (from phase 1, 2, and 3 clinical trials) to gain approval. Second, even when the monopoly is broken with the arrival of 'new and improved' versions of an approved drug, the older drug (and by now generic) tends to be viewed as substandard treatment, thereby perpetuating the situation. Third, the very nature of cancer, and the seriousness of the diagnosis, plays a role in that patients and physicians are often willing to pay the high price of treatment even for marginal improvements in outcome. Finally, because most cancers are incurable, patients are treated with each approved agent creating a virtual monopoly because the use of one drug does not automatically mean that the others are no longer needed.